| Primary thyroid lymphoma is a heterogeneous disease C Thieblemont, A Mayer, C Dumontet, Y Barbier, E Callet-Bauchu, ... The Journal of Clinical Endocrinology & Metabolism 87 (1), 105-111, 2002 | 417 | 2002 |
| Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene Q Zhang, R Siebert, M Yan, B Hinzmann, X Cui, L Xue, KM Rakestraw, ... MALT lymphoma with 1, 14, 1999 | 402 | 1999 |
| Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients F Berger, P Felman, C Thieblemont, T Pradier, L Baseggio, PA Bryon, ... Blood, The Journal of the American Society of Hematology 95 (6), 1950-1956, 2000 | 360 | 2000 |
| Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, ... Leukemia 22 (3), 487-495, 2008 | 318 | 2008 |
| Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study C Pott, E Hoster, MH Delfau-Larue, K Beldjord, S Böttcher, V Asnafi, ... Blood, The Journal of the American Society of Hematology 115 (16), 3215-3223, 2010 | 307 | 2010 |
| Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t (1; 14)(p22; q32) Q Zhang, R Siebert, M Yan, B Hinzmann, X Cui, L Xue, KM Rakestraw, ... nature genetics 22 (1), 63-68, 1999 | 298 | 1999 |
| Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the … H Avet-Loiseau, A Daviet, C Brigaudeau, E Callet-Bauchu, C Terré, ... Blood, The Journal of the American Society of Hematology 97 (3), 822-825, 2001 | 256 | 2001 |
| Mantle cell lymphoma: a retrospective study of 121 cases H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia, ... Leukemia 12 (8), 1281-1287, 1998 | 243 | 1998 |
| Splenic marginal-zone lymphoma: a distinct clinical and pathological entity C Thieblemont, P Felman, E Callet-Bauchu, A Traverse-Glehen, G Salles, ... The lancet oncology 4 (2), 95-103, 2003 | 225 | 2003 |
| Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients C Thieblemont, P Felman, F Berger, C Dumontet, P Arnaud, O Hequet, ... Clinical lymphoma 3 (1), 41-47, 2002 | 213 | 2002 |
| Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562 C Dumontet, K Fabianowska‐Majewska, D Mantincic, E Callet Bauchu, ... British journal of haematology 106 (1), 78-85, 1999 | 199 | 1999 |
| Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? A Traverse-Glehen, L Baseggio, EC Bauchu, D Morel, S Gazzo, M Ffrench, ... Blood, The Journal of the American Society of Hematology 111 (4), 2253-2260, 2008 | 173 | 2008 |
| Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome JF Larouche, F Berger, C Chassagne-Clément, M Ffrench, ... Journal of Clinical Oncology 28 (12), 2094-2100, 2010 | 158 | 2010 |
| Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients F Lachenal, F Berger, H Ghesquières, P Biron, A Hot, E Callet-Bauchu, ... Medicine 86 (5), 282-292, 2007 | 145 | 2007 |
| Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia D Poncet, A Belleville, C t'Kint de Roodenbeke, A Roborel de Climens, ... Blood, The Journal of the American Society of Hematology 111 (4), 2388-2391, 2008 | 142 | 2008 |
| Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia F Nguyen-Khac, J Lambert, E Chapiro, A Grelier, S Mould, C Barin, ... Haematologica 98 (4), 649, 2013 | 140 | 2013 |
| Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis C Thieblemont, V Nasser, P Felman, K Leroy, S Gazzo, E Callet-Bauchu, ... Blood 103 (7), 2727-2737, 2004 | 139 | 2004 |
| A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying at (14; 19)(q32; q13) or variant BCL3-translocation JI Martin-Subero, R Ibbotson, W Klapper, L Michaux, E Callet-Bauchu, ... Leukemia 21 (7), 1532-1544, 2007 | 132 | 2007 |
| CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases L Baseggio, A Traverse-Glehen, F Petinataud, E Callet-Bauchu, F Berger, ... haematologica 95 (4), 604, 2010 | 125 | 2010 |
| A clinicopathological study of nodal marginal zone B‐cell lymphoma. A report on 21 cases A Traverse‐Glehen, P Felman, E Callet‐Bauchu, S Gazzo, L Baseggio, ... Histopathology 48 (2), 162-173, 2006 | 120 | 2006 |
